220 related articles for article (PubMed ID: 10435639)
41. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen.
Shew JY; Chen PL; Bookstein R; Lee EY; Lee WH
Cell Growth Differ; 1990 Jan; 1(1):17-25. PubMed ID: 1964074
[TBL] [Abstract][Full Text] [Related]
42. Splicing mutations of the p53 gene in human hepatocellular carcinoma.
Lai MY; Chang HC; Li HP; Ku CK; Chen PJ; Sheu JC; Huang GT; Lee PH; Chen DS
Cancer Res; 1993 Apr; 53(7):1653-6. PubMed ID: 8384081
[TBL] [Abstract][Full Text] [Related]
43. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
Fernandes MJ; Hechtman P; Boulay B; Kaplan F
Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
[TBL] [Abstract][Full Text] [Related]
44. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
Rouer E; Dreyfus F; Melle J; Benarous R
Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
[TBL] [Abstract][Full Text] [Related]
45. Parathyroid hormone-like protein: alternative messenger RNA splicing pathways in human cancer cell lines.
Brandt DW; Wachsman W; Deftos LJ
Cancer Res; 1994 Feb; 54(3):850-3. PubMed ID: 8306349
[TBL] [Abstract][Full Text] [Related]
46. Exon trapping analysis of c.301-19G > A in intron 1 of the SHH gene in a patient with a microform of holoprosencephaly.
Kulseth MA; Lyle R; Rødningen OK; Sorte H; Prescott T
Eur J Med Genet; 2011; 54(2):130-5. PubMed ID: 21044704
[TBL] [Abstract][Full Text] [Related]
47. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans.
Ratech H; Denning S; Kaufman RE
Cell Immunol; 1997 May; 177(2):109-18. PubMed ID: 9178637
[TBL] [Abstract][Full Text] [Related]
48. A 3' splice site consensus sequence mutation in the intron 3 of the alpha-galactosidase A gene in a patient with Fabry disease.
Yokoi T; Shinoda K; Ohno I; Kato K; Miyawaki T; Taniguchi N
Jinrui Idengaku Zasshi; 1991 Sep; 36(3):245-50. PubMed ID: 1753437
[TBL] [Abstract][Full Text] [Related]
49. The association of nonsense mutation with exon-skipping in hprt mRNA of Chinese hamster ovary cells results from an artifact of RT-PCR.
Valentine CR; Heflich RH
RNA; 1997 Jun; 3(6):660-76. PubMed ID: 9174100
[TBL] [Abstract][Full Text] [Related]
50. Minigenes to confirm exon skipping mutations.
Desviat LR; Pérez B; Ugarte M
Methods Mol Biol; 2012; 867():37-47. PubMed ID: 22454053
[TBL] [Abstract][Full Text] [Related]
51. The Tgif2 gene contains a retained intron within the coding sequence.
Melhuish TA; Wotton D
BMC Mol Biol; 2006 Jan; 7():2. PubMed ID: 16436215
[TBL] [Abstract][Full Text] [Related]
52. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
[TBL] [Abstract][Full Text] [Related]
53. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant.
Ookawara T; Davé V; Willems P; Martin JJ; de Barsy T; Matthys E; Yoshida A
Arch Biochem Biophys; 1996 Mar; 327(1):35-40. PubMed ID: 8615693
[TBL] [Abstract][Full Text] [Related]
54. An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production.
Komori T; Sugiyama H
Immunology; 1995 May; 85(1):166-70. PubMed ID: 7635518
[TBL] [Abstract][Full Text] [Related]
55. Different mechanisms are responsible for the low accumulation of transcripts from intronless and 3' splice site deleted genes.
Bordonaro M; Nordstrom JL
Biochem Biophys Res Commun; 1994 Aug; 203(1):128-32. PubMed ID: 8074646
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the human dihydropyrimidine dehydrogenase gene.
Wei X; Elizondo G; Sapone A; McLeod HL; Raunio H; Fernandez-Salguero P; Gonzalez FJ
Genomics; 1998 Aug; 51(3):391-400. PubMed ID: 9721209
[TBL] [Abstract][Full Text] [Related]
57. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
[TBL] [Abstract][Full Text] [Related]
58. Insertion of a T next to the donor splice site of intron 1 causes aberrantly spliced mRNA in a case of infantile GM1-gangliosidosis.
Morrone A; Morreau H; Zhou XY; Zammarchi E; Kleijer WJ; Galjaard H; d'Azzo A
Hum Mutat; 1994; 3(2):112-20. PubMed ID: 8199591
[TBL] [Abstract][Full Text] [Related]
59. Serine 6 of Lck tyrosine kinase: a critical site for Lck myristoylation, membrane localization, and function in T lymphocytes.
Yasuda K; Kosugi A; Hayashi F; Saitoh S; Nagafuku M; Mori Y; Ogata M; Hamaoka T
J Immunol; 2000 Sep; 165(6):3226-31. PubMed ID: 10975838
[TBL] [Abstract][Full Text] [Related]
60. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
Shin S; Steffen DL
Oncogene; 1993 Jan; 8(1):141-9. PubMed ID: 8423992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]